EnotekAI

Revolutionizing Clinical Trials
with Intelligent Solutions

EnotekAI Inc created by Ailynix Inc, registered in North America and Asia SA, and created by Ailynix Inc is focused on the design and development of EnoPDCT

EnoPDCT an Artificial Intelligence (AI) Clinical Trial Platform that analyzes vast datasets of Genomic and Clinical information, predict patient responses to specific therapies, match patients to trials with high accuracy, and accelerate administrative tasks like data management.